NCT04580667View on ClinicalTrials.gov

Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation Toxicity

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

October 1, 2020

Primary Completion Date

September 6, 2023

Study Completion Date

September 6, 2023

Conditions
Prostate Cancer
Interventions
OTHER

Collection of plasma samples

Collection of plasma samples - Plasma samples are collected at different times during the study for the RadTox test.

Trial Locations (5)

10028

NY Cancer and Blood Specialists, New York

10469

NY Cancer and Blood Specialists, The Bronx

11776

NY Cancer and Blood Specialists, Port Jefferson Station

32206

UF Health Proton Therapy Institute, Jacksonville

32610

University of Florida, Gainesville, FL, Gainesville

Sponsors

Lead Sponsor

DiaCarta, Inc.
All Listed Sponsors
lead

DiaCarta, Inc.

INDUSTRY

NCT04580667 - Determination of Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict GI Radiation Toxicity | Biotech Hunter | Biotech Hunter